Clinical study to evaluate the efficiency of specific antibody against SARS-CoV-2 for the purpose of its social implementatio
Not Applicable
- Conditions
- Patients who are scheduled to be hospitalization to Yokohama City University Hospital and Yokohama City university medical center
- Registration Number
- JPRN-UMIN000040744
- Lead Sponsor
- Yokohama city university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3244
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who are already hospitalized (2) Patients suspected to be infected with COVID-19 such as common cold symptoms, upper respiratory tract symptoms, 37.5 degrees or more (3) Patients who are thought to have an effect on consent ability, such as mental illness (4) Patients with a new coronavirus infection in the past (5) Other patients who the investigator determined to be unsuitable for study participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fixed-point and time-course prevalence of NP antibody in patients without any clinical symptoms related to SARS-CoV-2
- Secondary Outcome Measures
Name Time Method